How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Cardiovascular Diagnostics, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
13 clearance records and 0 recall records in the covered releases, across 1 source company names and 8 product codes. Dated history runs from May 10, 1995 to Aug 23, 2002.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| ENOXAPARIN TEST CARDK013305 · KFF | Cardiovascular Diagnostics, Inc. | 510(k) | Aug 23, 2002FDA decision date |
| (TAS) LOW RANGE HEPARIN MANAGEMENT CARD RAPIDPOINTK994194 · JBP | Cardiovascular Diagnostics, Inc. | 510(k) | Mar 28, 2000FDA decision date |
| HMP CONTROLS (TAS) RAPIDPOINTK994159 · GGN | Cardiovascular Diagnostics, Inc. | 510(k) | Feb 15, 2000FDA decision date |
| RAPIDPOINT ACCENT, MODEL 2000, RAPIDPOINT COAG HEPARIN TITRATION TEST, RAPIDPOINT COAG PROTAMINE RESPONSE TESTK993519 · JOX | Cardiovascular Diagnostics, Inc. | 510(k) | Jan 14, 2000FDA decision date |
| TAS ANALYZER, MODEL 1009K990566 · JPA | Cardiovascular Diagnostics, Inc. | 510(k) | May 14, 1999FDA decision date |
| TAS RESULTS DATA ACQUISITION SYSTEM (TRAQS)K981206 · GKP | Cardiovascular Diagnostics, Inc. | 510(k) | May 26, 1998FDA decision date |
| THROMBOLYTIC ASSESSMENT SYSTEM LOW RANGE HEPARIN MANAGEMENT TEST CONTROLSK981178 · GGN | Cardiovascular Diagnostics, Inc. | 510(k) | Apr 27, 1998FDA decision date |
| TAS PT-NCTEST CONTROLSK971748 · GGN | Cardiovascular Diagnostics, Inc. | 510(k) | May 29, 1997FDA decision date |
| THROMBOLYTIC ASSESSMENT SYSTEM PROTHROMBIN TIME TEST CONTROLSK961814 · GIZ | Cardiovascular Diagnostics, Inc. | 510(k) | Aug 13, 1996FDA decision date |
| TAS A PTT TEST CONTROLSK961189 · GGN | Cardiovascular Diagnostics, Inc. | 510(k) | Jun 5, 1996FDA decision date |
| TAS HMT CONTROLSK960234 · GGN | Cardiovascular Diagnostics, Inc. | 510(k) | May 30, 1996FDA decision date |
| PROTHROMBIN TIME TEST CARDK954625 · GJS | Cardiovascular Diagnostics, Inc. | 510(k) | Mar 11, 1996FDA decision date |
| HEPARIN MANAGEMENT TEST CARD; HMT CARDK943283 · KFF | Cardiovascular Diagnostics, Inc. | 510(k) | May 10, 1995FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.